MedPath

Comparison of Onset, duration, quality of postoperative analgesia of epidurally administered Bupivacaine with Dexmedetomidine group and Bupivacaine with Buprenorphine group.

Not Applicable
Conditions
Health Condition 1: M170- Bilateral primary osteoarthritis of knee
Registration Number
CTRI/2023/10/058865
Lead Sponsor
vydehi institute of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)ASA 1 & 2

2)PATIENTS UNDERGOING TOTAL KNEE AND HIP REPLACEMENT SURGERIES

3)Uneventful intraoperative patients

Exclusion Criteria

1)ASA 3 & 4

2)ALLERGY TO LOCAL ANESTHETICS, DEXMEDETOMIDINE AND BUPRENORPHINE

3) BLEEDING AND NEUROMUSCULAR DISORDERS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare onset, duration, quality of postoperative analgesia of epidurally administered bupivacaine with dexmedetomidine and bupivacaine with buorenorphineTimepoint: To compare onset, duration, quality of postoperative analgesia of epidurally administered bupivacaine with dexmedetomidine and bupivacaine with buorenorphine
Secondary Outcome Measures
NameTimeMethod
assess and compare the haemodynamic parameters, side effects and time for ambulationTimepoint: after giving epidural topup onset of analgesia, sedation, duration of analgesia, haemodynamic parameters, mobilization time
© Copyright 2025. All Rights Reserved by MedPath